JOINN Biologics US
Latest round
- Series B
Last raised
- Aug 2021
Total raised
- $210M
Investors
- 6
About JOINN Biologics US
Based in California, US, and founded in 2018 by Shusheng Geng and Tao He, JOINN Biologics US Inc. is a pharmaceutical company that develops innovative drugs. The company has production facilities in both China and the US with more than 400 employees worldwide. The company's platform is a contract development and manufacturing organization (CDMO) that provides services across the entire drug development cycle. The company is engaged in cell line development and master cell bank (MCB) manufacturing, process and analytical development, formulation development, drug substance manufacturing, and drug product development services. The company also provides delivers packaged services for material production and investigational new drug enabling. The company plans to build a new facility in China that will have manufacturing capabilities of 100,00 liters of a bulk drug substance. The company also plans to build research and development and manufacturing centers in Beijing, Chongqing, and other Chinese cities.
Who invested in JOINN Biologics US
6 investors across 2 rounds
See all investors in JOINN Biologics US
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about JOINN Biologics US
Who invested in JOINN Biologics US?
JOINN Biologics US has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has JOINN Biologics US raised?
JOINN Biologics US has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did JOINN Biologics US last raise money?
JOINN Biologics US's most recent round on record is a Series B, in Aug 2021.
What does JOINN Biologics US do?
Based in California, US, and founded in 2018 by Shusheng Geng and Tao He, JOINN Biologics US Inc.
Where is JOINN Biologics US headquartered?
JOINN Biologics US is headquartered in Richmond, US.
Which VCs invest in companies like JOINN Biologics US?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at JOINN Biologics US's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like JOINN Biologics US? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.